Caprock Group, Inc. Verona Pharma PLC Transaction History
Caprock Group, Inc.
- $4.08 Billion
- Q3 2025
A detailed history of Caprock Group, Inc. transactions in Verona Pharma PLC stock. As of the latest transaction made, Caprock Group, Inc. holds 6,395 shares of VRNA stock, worth $683,689. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,395
Previous 5,987
6.81%
Holding current value
$683,689
Previous $380,000
79.47%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding VRNA
# of Institutions
264Shares Held
78.7MCall Options Held
686KPut Options Held
442K-
Pentwater Capital Management LP Naples, FL5.3MShares$567 Million3.55% of portfolio
-
Ubs Oconnor LLC Chicago, IL4.28MShares$458 Million27.57% of portfolio
-
Hbk Investments L P Dallas, TX4.26MShares$456 Million6.29% of portfolio
-
Fil LTD Hamilton, D03.49MShares$373 Million0.32% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$362 Million15.27% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.52B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...